Hochschulschrift
Meropenem versus Imipenem, Cilastatin : eine offene, multizentrische, in Parallelgruppen gegliederte Vergleichsstudie in der Behandlung von schweren nosokomialen Infektionen
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Dimensions
-
30 cm
- Extent
-
52, XXXIV Bl.
- Language
-
Deutsch
- Notes
-
graph. Darst.
Münster (Westfalen), Univ., Diss., 1998
- Creator
- Table of contents
- Rights
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Last update
-
11.06.2025, 1:32 PM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
Other Objects (12)
Zur In-vitro-Wirksamkeit von Imipenem und Meropenem auf Staphylokokken und Enterokokken
Antibakterieller Einfluss von Imipenem (MK-787) und Meropenem (SM-7338) auf Enterobacteriaceae und Pseudomonadaceae
Efficacy of ceftazidime-avibactam, meropenem-vaborbactam, and imipenem-relebactam combinations against carbapenemase-producing Enterobacterales in Switzerland
In vitro antibacterial activity of rifampicin in combination with imipenem, meropenem and doripenem against multidrug-resistant clinical isolates of Pseudomonas aeruginosa
Comparative in vitro activity of Meropenem, Imipenem and Piperacillin/tazobactam against 1071 clinical isolates using 2 different methods: a French multicentre study
Qualitätssicherung in der nosokomialen Infektiologie
Upstream region of OprD mutations in imipenem-resistant and imipenem-sensitive Pseudomonas isolates
Meropenem: continuous or extended infusion?
The importance of meropenem resistance, rather than imipenem resistance, in defining carbapenem-resistant Enterobacterales for public health surveillance: an analysis of national population-based surveillance
Pharmakokinetik von Ceftriaxon und Imipenem/Cilastatin
Multizentrische Retikulohistiozytose
Activity of imipenem/relebactam and comparators against KPC-producing Klebsiella pneumoniae and imipenem-resistant Pseudomonas aeruginosa
Zur In-vitro-Wirksamkeit von Imipenem und Meropenem auf Staphylokokken und Enterokokken
Antibakterieller Einfluss von Imipenem (MK-787) und Meropenem (SM-7338) auf Enterobacteriaceae und Pseudomonadaceae
Efficacy of ceftazidime-avibactam, meropenem-vaborbactam, and imipenem-relebactam combinations against carbapenemase-producing Enterobacterales in Switzerland
In vitro antibacterial activity of rifampicin in combination with imipenem, meropenem and doripenem against multidrug-resistant clinical isolates of Pseudomonas aeruginosa
Comparative in vitro activity of Meropenem, Imipenem and Piperacillin/tazobactam against 1071 clinical isolates using 2 different methods: a French multicentre study
Qualitätssicherung in der nosokomialen Infektiologie
Upstream region of OprD mutations in imipenem-resistant and imipenem-sensitive Pseudomonas isolates
Meropenem: continuous or extended infusion?
The importance of meropenem resistance, rather than imipenem resistance, in defining carbapenem-resistant Enterobacterales for public health surveillance: an analysis of national population-based surveillance
Pharmakokinetik von Ceftriaxon und Imipenem/Cilastatin
Multizentrische Retikulohistiozytose
Activity of imipenem/relebactam and comparators against KPC-producing Klebsiella pneumoniae and imipenem-resistant Pseudomonas aeruginosa
Zur In-vitro-Wirksamkeit von Imipenem und Meropenem auf Staphylokokken und Enterokokken
Antibakterieller Einfluss von Imipenem (MK-787) und Meropenem (SM-7338) auf Enterobacteriaceae und Pseudomonadaceae
Efficacy of ceftazidime-avibactam, meropenem-vaborbactam, and imipenem-relebactam combinations against carbapenemase-producing Enterobacterales in Switzerland
In vitro antibacterial activity of rifampicin in combination with imipenem, meropenem and doripenem against multidrug-resistant clinical isolates of Pseudomonas aeruginosa
Comparative in vitro activity of Meropenem, Imipenem and Piperacillin/tazobactam against 1071 clinical isolates using 2 different methods: a French multicentre study
Qualitätssicherung in der nosokomialen Infektiologie
Upstream region of OprD mutations in imipenem-resistant and imipenem-sensitive Pseudomonas isolates
Meropenem: continuous or extended infusion?
The importance of meropenem resistance, rather than imipenem resistance, in defining carbapenem-resistant Enterobacterales for public health surveillance: an analysis of national population-based surveillance
Pharmakokinetik von Ceftriaxon und Imipenem/Cilastatin
Multizentrische Retikulohistiozytose